NBD AI Bulletin,Beijing SL Pharmaceutical Co., Ltd. (SZ 002038, closing price: 11.50 yuan) announced on the evening of May 22 that Xinxiang Bailu Investment Group Co., Ltd. pledged 4 million shares, or 1.89 percent of shares it owns, on May 19, 2020. As of the date of disclosure of the announcement, 95.5 million shares of the company held by Xinxiang Bailu have been pledged. 

According to the 2019 Annual Report, Beijing SL Pharmaceutical Co., Ltd.'s mainly engages in pharmaceutical-related businesses, accounting for 98.96% of revenue.

Beijing SL Pharmaceutical Co., Ltd.'s chairman and general manager is Xu Mingbo: male, 56 years old, PhD. graduate of the Academy of Military Medical Sciences, professorial senior engineer.

(By Li Menglin)

Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.